Cargando…

Curated Database and Preliminary AutoML QSAR Model for 5-HT1A Receptor

Introduction of a new drug to the market is a challenging and resource-consuming process. Predictive models developed with the use of artificial intelligence could be the solution to the growing need for an efficient tool which brings practical and knowledge benefits, but requires a large amount of...

Descripción completa

Detalles Bibliográficos
Autores principales: Czub, Natalia, Pacławski, Adam, Szlęk, Jakub, Mendyk, Aleksander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536971/
https://www.ncbi.nlm.nih.gov/pubmed/34684004
http://dx.doi.org/10.3390/pharmaceutics13101711
_version_ 1784588136532148224
author Czub, Natalia
Pacławski, Adam
Szlęk, Jakub
Mendyk, Aleksander
author_facet Czub, Natalia
Pacławski, Adam
Szlęk, Jakub
Mendyk, Aleksander
author_sort Czub, Natalia
collection PubMed
description Introduction of a new drug to the market is a challenging and resource-consuming process. Predictive models developed with the use of artificial intelligence could be the solution to the growing need for an efficient tool which brings practical and knowledge benefits, but requires a large amount of high-quality data. The aim of our project was to develop quantitative structure–activity relationship (QSAR) model predicting serotonergic activity toward the 5-HT1A receptor on the basis of a created database. The dataset was obtained using ZINC and ChEMBL databases. It contained 9440 unique compounds, yielding the largest available database of 5-HT1A ligands with specified pKi value to date. Furthermore, the predictive model was developed using automated machine learning (AutoML) methods. According to the 10-fold cross-validation (10-CV) testing procedure, the root-mean-squared error (RMSE) was 0.5437, and the coefficient of determination (R(2)) was 0.74. Moreover, the Shapley Additive Explanations method (SHAP) was applied to assess a more in-depth understanding of the influence of variables on the model’s predictions. According to to the problem definition, the developed model can efficiently predict the affinity value for new molecules toward the 5-HT1A receptor on the basis of their structure encoded in the form of molecular descriptors. Usage of this model in screening processes can significantly improve the process of discovery of new drugs in the field of mental diseases and anticancer therapy.
format Online
Article
Text
id pubmed-8536971
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85369712021-10-24 Curated Database and Preliminary AutoML QSAR Model for 5-HT1A Receptor Czub, Natalia Pacławski, Adam Szlęk, Jakub Mendyk, Aleksander Pharmaceutics Article Introduction of a new drug to the market is a challenging and resource-consuming process. Predictive models developed with the use of artificial intelligence could be the solution to the growing need for an efficient tool which brings practical and knowledge benefits, but requires a large amount of high-quality data. The aim of our project was to develop quantitative structure–activity relationship (QSAR) model predicting serotonergic activity toward the 5-HT1A receptor on the basis of a created database. The dataset was obtained using ZINC and ChEMBL databases. It contained 9440 unique compounds, yielding the largest available database of 5-HT1A ligands with specified pKi value to date. Furthermore, the predictive model was developed using automated machine learning (AutoML) methods. According to the 10-fold cross-validation (10-CV) testing procedure, the root-mean-squared error (RMSE) was 0.5437, and the coefficient of determination (R(2)) was 0.74. Moreover, the Shapley Additive Explanations method (SHAP) was applied to assess a more in-depth understanding of the influence of variables on the model’s predictions. According to to the problem definition, the developed model can efficiently predict the affinity value for new molecules toward the 5-HT1A receptor on the basis of their structure encoded in the form of molecular descriptors. Usage of this model in screening processes can significantly improve the process of discovery of new drugs in the field of mental diseases and anticancer therapy. MDPI 2021-10-16 /pmc/articles/PMC8536971/ /pubmed/34684004 http://dx.doi.org/10.3390/pharmaceutics13101711 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Czub, Natalia
Pacławski, Adam
Szlęk, Jakub
Mendyk, Aleksander
Curated Database and Preliminary AutoML QSAR Model for 5-HT1A Receptor
title Curated Database and Preliminary AutoML QSAR Model for 5-HT1A Receptor
title_full Curated Database and Preliminary AutoML QSAR Model for 5-HT1A Receptor
title_fullStr Curated Database and Preliminary AutoML QSAR Model for 5-HT1A Receptor
title_full_unstemmed Curated Database and Preliminary AutoML QSAR Model for 5-HT1A Receptor
title_short Curated Database and Preliminary AutoML QSAR Model for 5-HT1A Receptor
title_sort curated database and preliminary automl qsar model for 5-ht1a receptor
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536971/
https://www.ncbi.nlm.nih.gov/pubmed/34684004
http://dx.doi.org/10.3390/pharmaceutics13101711
work_keys_str_mv AT czubnatalia curateddatabaseandpreliminaryautomlqsarmodelfor5ht1areceptor
AT pacławskiadam curateddatabaseandpreliminaryautomlqsarmodelfor5ht1areceptor
AT szlekjakub curateddatabaseandpreliminaryautomlqsarmodelfor5ht1areceptor
AT mendykaleksander curateddatabaseandpreliminaryautomlqsarmodelfor5ht1areceptor